Evidence map›Paper›PMID 39601281›Full record

ReviewGut microbes

Unraveling the gut-skin axis in atopic dermatitis: exploiting insights for therapeutic strategies.

Marcela Rios-Carlos, Daniel Cervantes-García, Laura E Córdova-Dávalos, Luis G Bermúdez-Humarán, Eva Salinas

Abstract readReview
In one paragraph

Review in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. [Gut microbiota and allergic diseases].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marcela Rios-CarlosDepartment of Microbiology, Universidad Autónoma de Aguascalientes. Av. Universidad 940, Aguascalientes, Mexico.ORCID 0009-0009-6655-9038
Daniel Cervantes-GarcíaDepartment of Microbiology, Universidad Autónoma de Aguascalientes. Av. Universidad 940, Aguascalientes, Mexico.ORCID 0000-0002-9711-8042
Laura E Córdova-DávalosDepartment of Microbiology, Universidad Autónoma de Aguascalientes. Av. Universidad 940, Aguascalientes, Mexico.ORCID 0000-0001-5373-5308
Luis G Bermúdez-HumaránINRAE, Université Paris-Saclay, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.ORCID 0000-0001-7525-3131
Eva SalinasDepartment of Microbiology, Universidad Autónoma de Aguascalientes. Av. Universidad 940, Aguascalientes, Mexico.ORCID 0000-0002-3570-7255

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbiota exert functions of high importance in the intestine. Furthermore, there is increasing evidence for its role in immune regulation and maintenance of homeostasis in many physiological processes taking place in distant tissues. In particular, in this review, we explore the impact of metabolites produced by the gut microbiota on the development of atopic dermatitis (AD). Probiotics and prebiotics balance the microbiota and promote the generation of bacterial metabolites, such as short-chain fatty acids and tryptophan derivates, which promote the regulation of the exacerbated AD immune response through regulatory T cells and IL-10 and TGF-β cytokines. Metabolites also have a direct action on keratinocytes once they reach the bloodstream. Besides, probiotics decrease the levels of metabolites associated with AD onset, such as phenols. Understanding all these crosstalk processes between the gut and the skin reveals a number of possibilities, mainly through the manipulation of the gut microbiome, which may represent therapeutic strategies that can contribute to the standard treatments of AD patients to improve their quality of life.

Indexed as

Dermatitis, AtopicGastrointestinal MicrobiomePrebioticsProbioticsSkinAnimalsBacteriaFatty Acids, VolatileHumansFatty Acids, VolatilePrebioticsAtopic dermatitisgut microbiomegut-skin axisphenolsprebioticsprobioticsshort-chain fatty acidstryptophan metabolites

Identifiers

PMID39601281
PMCPMC11610564

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.